Previous Article | Next Article 
Journal of Clinical Microbiology, November 2000, p. 4292-4293, Vol. 38, No. 11
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Peritonitis Due to Brevibacterium otitidis in a
Patient Undergoing Continuous Ambulatory Peritoneal Dialysis
Georges
Wauters,1,*
Bernard
Van Bosterhaut,2
Véronique
Avesani,1
René
Cuvelier,2
Jacqueline
Charlier,1
Michèle
Janssens,1 and
Michel
Delmée1
Microbiology Unit, Faculty of Medicine,
University of Louvain, B-1200 Brussels,1 and
Centre Hospitalier de Mouscron, 7700 Mouscron,2 Belgium
Received 23 May 2000/Returned for modification 25 July
2000/Accepted 22 August 2000
 |
ABSTRACT |
Brevibacterium otitidis is a coryneform rod and, as far
as is known, is isolated only from infected ears. We report the first known case of peritonitis caused by B. otitidis in a
patient undergoing continuous ambulatory peritoneal dialysis.
 |
CASE REPORT |
A 73-year-old woman was started on
continuous ambulatory peritoneal dialysis (CAPD) in May 1997 because of
renal insufficiency due to nephrosclerosis. In November 1998, peritonitis with methicillin-resistant, coagulase-negative
Staphylococcus sp. was diagnosed and treated with
intraperitoneally administered vancomycin, resulting in clinical resolution within 48 h.
In September 1999, the patient complained of moderate abdominal pain,
her temperature was 37.5°C, and the dialysate effluent was cloudy.
The subcutaneous tunnel and the exit site of the CAPD catheter were
unremarkable. The cell count of the effluent disclosed 160 white blood
cells/mm3, of which 46% were polymorphonuclear
neutrophils. Her peripheral leukocyte count was 6,870/mm3,
and the C-reactive protein level was 2.0 mg/dl. Other results disclosed
a state of relative malnutrition, with an albuminemia of 3.2 g/dl and a
total cholesterol level of 144 mg/dl.
Empirical intraperitoneal therapy with cefazolin and gentamicin was
initiated, and rapid clearing of the effluent resulted. On follow-up
dialysate examination 5 days after institution of therapy, no
significant numbers of leukocytes were seen. Subsequently, we clearly
identified the cause of the infection as inadequate manipulation
of the bag connector with a screwdriver.
Microbiological findings.
The dialysate was cultured on blood
agar plates, and 10 ml was inoculated into a blood culture bottle
(BACTEC plus aerobic/F*). All cultures grew a gram-positive coryneform
rod. Colonies were smooth and slightly yellowish. There was no growth
at 20°C. The organism was nonmotile, catalase positive, and urease
negative and did not acidify any carbohydrates. Gelatin and casein were hydrolyzed. Methane-thiol production was rapidly positive. Nitrate was
not reduced. There was no hydrolysis of esculin, xanthine, or tyrosine.
No carbohydrates were utilized as shown by the API 50 CH panel
(bioMérieux, Marcy l'Etoile, France). Pyrrolidonyl peptidase was
strongly positive, but
-glucosidase was negative. The numerical code
achieved by the API Coryne strip (bioMérieux) was 6002004, corresponding to Arthrobacter spp. or
Brevibacterium spp. The cellular fatty acids analyzed by
gas-liquid chromatography (Delsi chromatograph, Intersmat, Brussels,
Belgium) were predominantly of the branched type, with anteiso 15:0 and
anteiso 17:0 accounting for more than 75% of the total. The diamino
acid of the peptidoglycan was meso-diaminopimelic acid, as
determined by N. Weiss at the German Collection of Microorganisms and
Cell Cultures (Braunschweig, Germany).
The 16S rRNA gene sequence of the strain was studied using a set of
primers for amplification. PCR products were purified from agarose gel
by the QIAquick Gel Extraction kit (Qiagen, Westburg, The Netherlands).
Analysis of the whole sequence was performed with an automatic DNA
sequencer (Perkin-Elmer, Applied Biosystems, Foster City, Calif.) using
the ABI Prism Big Dye Terminator Cycle Sequencing Ready Reaction kit.
Each sequence was compared to the sequence data available in databases
using BLAST (7). The 16S rRNA gene sequence of the strain
exhibited 98.8% similarity to that of the type strain of
Brevibacterium otitidis, DSM 10718T.
The overall phenotypic findings and the chemotaxonomic characteristics
of the strain were consistent with those of the genus
Brevibacterium (
3). The biochemical profile
(Table
1) allowed
us to assign it to the
species
B. otitidis (
6). Although the
16S rRNA
gene sequence similarity of 98.8% seems somewhat low,
it is
nevertheless compatible with isolates from the same species
(
8).
Susceptibility of the strain was tested by the disk diffusion method on
Mueller-Hinton blood agar incubated at 37°C for 24
h. Paper
disks (Becton Dickinson, Cockeysville, Md.) containing
penicillin,
ampicillin, cefotaxime, cephalothin, erythromycin,
ciprofloxacin,
gentamicin, and vancomycin were used, and the results
were interpreted
in accordance with the criteria established for
staphylococci by the
National Committee for Clinical Laboratory
Standards in 1997 (
5a). The isolate was susceptible to all of
the antibiotics
tested.
Discussion.
Poor socioeconomic conditions and the low
education level of the patient, resulting in inadequate manipulation of
the bag connector, may explain the recurrent episodes of peritonitis
during her CAPD treatment. Her relative malnutrition may have also
contributed to the infection.
Coryneform bacteria belonging to the genus
Brevibacterium
have been increasingly involved as opportunistic pathogens in various
clinical, mostly nosocomial, settings (
3). The vast majority
of the isolates are
B. casei (
2). Brevibacteria
have already
been isolated in cases of CAPD peritonitis (
4).
Four strains
studied by Funke and Carlotti and isolated from peritoneal
dialysate
belonged to the species
B. casei (
2).
One strain of
B. iodinum was isolated from the peritoneal
fluid of a CAPD patient with
peritonitis associated with acute
urticaria (
1).
B. iodinum has, to the best of our
knowledge, never been isolated from humans
in other instances, and it
must be noted that the description
of the isolate in the foregoing
study was very limited and that
the species identification was based
only on the oxidase test.
B. otitidis is a new species
recently described and has so far
been isolated only from infected
human ears (
6). Our isolate
is the first of
B. otitidis recovered as a relevant pathogen outside
the
ear.
Brevibacterium sp. should be differentiated from other
nonfermentative coryneform bacteria, especially
Arthrobacter
spp.,
nonfermenting
Microbacterium (formerly
Aureobacterium) species,
and "
Corynebacterium
aquaticum." Chemotaxonomic properties are
useful for this
purpose, as the peptidoglycan of these genera
does not contain
meso-diaminopimelic acid (
3). Some
Arthrobacter species may be difficult to distinguish from
Brevibacterium sp.
routinely. Strong and rapid methane-thiol
production is helpful
to confirm brevibacteria. The former
Aureobacterium species, recently
transferred to the genus
Microbacterium (
9), and "
C.
aquaticum"
are also yellow pigmented, but they oxidatively
acidify carbohydrates,
in contrast to brevibacteria.
B. otitidis is metabolically less
active than
B. casei and
B. epidermidis and is similar in this
respect to
B. mcbrellneri (
6). However, colonies of
B. otitidis are smooth and yellowish while those of
B. mcbrellneri are dry
and crumbly (
5). In addition,
pyrrolidonyl peptidase is strongly
positive in
B. otitidis
and negative in
B. mcbrellneri. The main
differential
characteristics of
Brevibacterium species isolated
from
clinical specimens are reported in Table
1.
This observation emphasizes the need to identify coryneform bacteria
more accurately for better assessment of their pathogenic
role in
opportunistic
infections.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: University of
Louvain, Microbiology Unit, UCL/5490, Ave. Hippocrate 54, B-1200
Brussels, Belgium. Phone: 32(0)2 7645490. Fax: 32(0)2 7649440. E-mail:
wauters{at}mblg.ucl.ac.be.
 |
REFERENCES |
| 1.
|
Antoniou, S.,
A. Dimitriadis,
F. Polydorou, and E. Malaka.
1997.
Brevibacterium iodinum peritonitis associated with acute urticaria in a CAPD patient.
Perit. Dial. Int.
17:614-615[Free Full Text].
|
| 2.
|
Funke, G., and A. Carlotti.
1994.
Differentiation of Brevibacterium spp. encountered in clinical specimens.
J. Clin. Microbiol.
32:1729-1732[Abstract/Free Full Text].
|
| 3.
|
Funke, G.,
A. von Graevenitz,
J. E. Clarridge III, and K. A. Bernard.
1997.
Clinical microbiology of coryneform bacteria.
Clin. Microbiol. Rev.
10:125-159[Abstract].
|
| 4.
|
Gruner, E.,
G. E. Pfyffer, and A. von Graevenitz.
1993.
Characterization of Brevibacterium spp. from clinical specimens.
J. Clin. Microbiol.
31:1408-1412[Abstract/Free Full Text].
|
| 5.
|
McBride, M. E.,
K. M. Ellner,
H. S. Black,
J. E. Clarridge, and J. E. Wolf.
1993.
A new Brevibacterium sp. isolated from infected genital hair of patients with white piedra.
J. Med. Microbiol.
39:255-261[Abstract/Free Full Text].
|
| 5a.
|
National Committee for Clinical Laboratory Standards.
1997.
Performance standards for antimicrobial disk susceptibility tests, 6th ed. Approved standard.
National Committee for Clinical Laboratory Standards, Villanova, Pa.
|
| 6.
|
Pascual, C.,
M. D. Collins,
G. Funke, and D. G. Pitcher.
1996.
Phenotypic and genotypic characterisation of two Brevibacterium strains from the human ear: description of Brevibacterium otitidis sp. nov.
Med. Microbiol. Lett.
5:113-123.
|
| 7.
|
Pearson, W. R., and D. J. Lipman.
1998.
Improved tools for biological sequence comparison.
Proc. Natl. Acad. Sci. USA
85:2444-2448.
|
| 8.
|
Stackebrandt, E., and B. M. Goebel.
1994.
Taxonomic note: a place for DNA-DNA reassociation and 16S rRNA sequence analysis in the present species definition in bacteriology.
Int. J. Syst. Bacteriol.
44:846-849[Abstract/Free Full Text].
|
| 9.
|
Takeuchi, M., and K. Hatano.
1998.
Union of the genera Microbacterium Orlajensen and Aureobacterium Collins et al. in a redefined genus Microbacterium.
Int. J. Syst. Bacteriol.
48:739-747[Abstract/Free Full Text].
|
Journal of Clinical Microbiology, November 2000, p. 4292-4293, Vol. 38, No. 11
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Roux, V., Raoult, D.
(2009). Brevibacterium massiliense sp. nov., isolated from a human ankle discharge. Int. J. Syst. Evol. Microbiol.
59: 1960-1964
[Abstract]
[Full Text]
-
Mages, I. S., Frodl, R., Bernard, K. A., Funke, G.
(2008). Identities of Arthrobacter spp. and Arthrobacter-Like Bacteria Encountered in Human Clinical Specimens. J. Clin. Microbiol.
46: 2980-2986
[Abstract]
[Full Text]
-
Wauters, G., Avesani, V., Laffineur, K., Charlier, J., Janssens, M., Van Bosterhaut, B., Delmee, M.
(2003). Brevibacterium lutescens sp. nov., from human and environmental samples. Int. J. Syst. Evol. Microbiol.
53: 1321-1325
[Abstract]
[Full Text]